Rheumatology Highlights Report
Osteoarthritis &
Miscellaneous Rheumatic Disorders
 |
||
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: January 20, 2012
Expiration Date: January 20, 2013
Estimated Time of Completion: 15 minutes
Description
The Rheumatology Highlights Report Series is designed for the busy clinician. It provides highlights from key scientific presentations and/or abstracts presented at the national rheumatology meeting. Clinical experts attending this meeting have selected the most significant data to report. Each activity is a 15-minute presentation. Enhancements include downloadable audio and slide sets, and supporting abstracts with expert commentaries. This series offer two methods of participation: on your computer or mobile device.
Learning Objectives
- Assess the effects of diet and exercise on symptom reduction in patients with knee osteoarthritis.
- Consider the use of IL-1 inhibitors to treat familial Mediterranean fever and Schnitzler syndrome.
- Appraise the relative risks of progressive multifocal leukoencephalopathy developing in patients with autoimmune rheumatic diseases treated with various immunosuppressive agents.
Target Audience
This activity is directed to rheumatologists, immunologists, rheumatology and immunology fellows, clinical researchers, and rheumatology and immunology allied health professionals, including nurse practitioners and physician assistants.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Activity Director
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R. J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Faculty
Jonathan Kay, MD
Professor of Medicine
Director of Clinical Research, Division of Rheumatology
University of Massachusetts School of Medicine
Worcester, MA
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated that he may have a relationship which, in the context of his presentations, could be perceived as a potential conflict of interest:
| Leonard H. Calabrese, DO | ||
| Abbott Laboratories; Amgen, Inc.; Centocor; Genentech/Roche; Pfizer | Consulting, Teaching & Speaking | |
| BMS; Elan Pharmaceuticals, Inc.; Wyeth | Consulting | |
The following faculty has indicated he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Jonathan Kay, MD
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants
for partial support of this activity from:
Amgen, Inc.
Pfizer, Inc.
Abbott Laboratories Inc.
Genentech & Biogen Idec
UCB, Inc.
Human Genome Sciences, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and the R.J. Fasenmyer Center for Clinical Immunology.
